EYPT vs BIO
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 16, 2026
EYPT
BIO
Investment Advisor Scores
BIO
AI Analyst Insights
Detailed Metrics Comparison
| Metric | EYPT | BIO | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 6.1614 | 38.9105 | EYPT |
| PEG Ratio | 0 | 1.1905 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 161.7% | -0.1% | EYPT |
| Earnings Growth | 0.0% | 18.7% | BIO |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 41.7/100 | 38.6/100 | EYPT |
| Profit Margin | 0.0% | 8.6% | BIO |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | SELL | EYPT |
Relative Price Performance (Last 90 Days)
Current Technical Phase
EYPT
MarkdownPrice below a falling SMA50 (slope -4.0%), weak momentum, RSI 30
BIO
MarkupPrice above SMA50, rising 50-day trend (7.9% over 20 days), RSI 78
Fundamentals Snapshot
| Metric | EYPT | BIO |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -1.8 | 37.5 |
| Trailing P/E | — | 42.9 |
| Revenue (TTM) | — | — |
| Revenue Growth | 1.6% | 0.0% |
| Gross Margin | -92.4% | 0.5% |
| Operating Margin | -4.5% | 0.1% |
| EPS | -4.33 | 8.49 |
| Dividend Yield | — | — |